BK polyomavirus nephropathy (BKVN) and allograft rejection are two closely-associated
diseases on opposite ends of the immune scale in kidney transplant recipients. The principle …

Background: Various population pharmacokinetic models have been developed to describe
the pharmacokinetics of tacrolimus in adult liver transplantation. However, their extrapolated …

Background: Monitoring and maintaining a stable tacrolimus trough level is essential
because of its narrow therapeutic window and considerable fluctuation in the early phase …

Risk factors and etiology of repeat infection in kidney tran... : Medicine Risk factors and etiology
of repeat infection in kidney transplant recipients : Medicine Log in or Register Get new issue …

Background Infection after a kidney transplant is a serious cause of morbidity and mortality.
Weighing the risks and benefits of immunosuppression is of paramount importance for …

Background Trough‐adjusted tacrolimus is commonly prescribed following intestinal
transplantation to prevent allograft rejection. Despite established practice, there remains …

Background Although tacrolimus is an effective immunosuppressive drug used for
preventing biopsy proven acute rejection (BPAR) in kidney transplanted patients, its …

Introduction Infectious complications remain a common cause of mortality after kidney
transplantation (KTx). Goal of effective immunosuppressive treatment (IS) must be balanced …

Background: The current study aimed to determine the optimal tacrolimus trough levels for
balancing graft survival and patient safety following kidney transplantation. Materials and …

Background: Maintaining the exposure of tacrolimus (Tac) after kidney transplantation (KT)
must be necessary to prevent acute rejection (AR) and improve graft survival# 140; but there …